Chronic Kidney Disease Major Risk Factor for COVID-19 Severity and Mortality, A Scoping Review
Abstract
A growing body of evidence points out at chronic kidney disease (CKD) as a major risk factor for severe COVID-19, increasing also the respective mortality risk. Preventive measures, rapid monitoring organ function and interventions capable of preventing multiorgan failures are of great importance to reduce adverse outcomes in COVID-19 patients with CKD. While efforts are underway to carry out indirect protection interventions and large-scale vaccination to achieve herd immunity in the general population, direct protection of patients with CKD through rapid vaccination trials are necessary since uraemia and immunosuppressive agents could have a negative impact on vaccination responses of CDK patients. More epidemiological data are needed for in-depth understanding of the course and outcome of COVID-19 in CKD patients, supporting clinical decision-making.
DOI: 10.52547/ijkd.6797
Downloads
Download data is not yet available.
Downloads
Published
2021-09-09
Issue
Section
BRIEF REVIEW | Kidney Diseases
How to Cite
Chronic Kidney Disease Major Risk Factor for COVID-19 Severity and Mortality, A Scoping Review. (2021). Iranian Journal of Kidney Diseases, 15(5), 323-326. https://www.ijkd.org/index.php/ijkd/article/view/6797